Home > Financial Ratios > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
Fixed Capital/Sales

    Back to All Ratios
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ADVANCED ENZYME TECHNOLOGIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.471.421.551.471.44

What is the latest Fixed Capital/Sales ratio of ADVANCED ENZYME TECHNOLOGIES ?

The latest Fixed Capital/Sales ratio of ADVANCED ENZYME TECHNOLOGIES is 1.47 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.47
Mar20241.42
Mar20231.55
Mar20221.47
Mar20211.44

How is Fixed Capital/Sales of ADVANCED ENZYME TECHNOLOGIES Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.47
3.52
Mar2024 1.42
-8.39
Mar2023 1.55
5.44
Mar2022 1.47
2.08
Mar2021 1.44 -

Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES


Compare Fixed Capital/Sales ratio of peers of ADVANCED ENZYME TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES ₹3,346.9 Cr 6.4% 2.3% 7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ADVANCED ENZYME TECHNOLOGIES

6.4%

2.3%

7.1%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses